Accession Number: | 0001209191-21-017479 |
Date: | 2021-03-01 |
Issuer: | SURFACE ONCOLOGY, INC. (SURF) |
Original Submission Date: |
PALOMBELLA VITO J.
C/O SURFACE ONCOLOGY, INC.
50 HAMPSHIRE STREET, 8TH FLOOR
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 9.02 | 2021-03-01 | deemed execution date | A | 82,000 (a) | 2031-03-01 | common stock 82,000 | $9.02 | 82,000 | direct |
ID | footnote |
---|---|
f1 | this option shall become exercisable in equal monthly installments over four years following february 9, 2021, so long as the reporting person remains an employee or other service provider of the company on such dates. |